This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 31145354
Submitted by lobbyist on: February 20, 2017 11:42:14 AM
Accepted by Registrar on: February 20, 2017 04:25:12 PM
Lobbyist Information
Vander Wal, Steve |
355 Burrard Street, Site 1350 | |
Vancouver, BC, V6C 2G8
|
604-692-4221 |
Canada |
BC Public Office Background
Public Office Title | Description of Role | From | To |
---|---|---|---|
Political Staff | Executive Assistant to the Minister of Health Services; Ministerial Assistant to the Minister of Advanced Education & Research and Deputy Premier; Ministerial Assistant to the Minister of Health Services | 09/09/2002 | 02/10/2006 |
Lobbyist Firm Information
Hill+Knowlton Strategies |
355 Burrard Street, Site 1350 | |
Vancouver, BC, V6C 2G8
|
604-692-4221 |
Canada |
Client Information
Seqirus |
Global specialty biotechnology company that researches, develops, manufactures and markets products to treat and prevent serious human medical conditions. |
385 Bouchard Blvd | |
Dorval, QC, H9S 1A9
|
514-631-6775 |
Canada |
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
February 20, 2017 | |
April 30, 2017 |
There are no other individuals engaged to lobby on this undertaking.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder
Development, establishment, amendment or termination of any program, policy or decision
Engage government on the role the company plays in providing vaccines to government
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Minister of Health | February 20, 2017 | |
Public Agency | Health | February 20, 2017 |